Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy

American Journal of Cardiology

Volumn 95, Issue 5, 2005, Pages 558-564

  O'Connor, Christopher M ^a   Gottlieb, Steven ^b   Bourque, Jamieson M ^b   Krause Steinrauf, Heidi ^b   Anand, Inder ^b   Anderson, Jeffrey L ^b   Plehn, Jonathan F ^b   Silver, Marc A ^b   White, Michel ^b   Carson, Peter ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUCINDOLOL;

ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GENDER; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SAMPLE SIZE; STATISTICAL MODEL; SURVIVAL RATE; SYMPTOM; TREATMENT OUTCOME;

EID: 13844256336     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.11.001     Document Type: Article

References (28)

1. J.B. Kostis, A.C. Wilson, M.R. Sanders, R.P. Byington BHAT Study Group Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction who receive propranolol Am J Cardiol 61 1988 975 978
2. R. Roberts, W.J. Rogers, H.S. Mueller, C.T. Lambrew, D.J. Diver, H.C. Smith, J.T. Willerson, G.L. Knatterud, S. Forman, E. Passamani Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction Results of the Thrombolysis In Myocardial Infarction (TIMI) II-B Study Circulation 83 1991 422 437
3. The MIAMI Trial Research Group Metoprolol in acute myocardial infarction (MIAMI) A randomised placebo-controlled international trial Eur Heart J 6 1985 199 226
4. First International Study of Infarct Survival Collaborative Group Randomised trial of intravenous atenolol among 16,207 cases of suspected acute myocardial infarction: ISIS-1 Lancet 2 1986 57 66
5. J.R. Kaplan, S.B. Manuck Antiatherogenic effects of beta-adrenergic blocking agents: theoretical, experimental, and epidemiologic considerations Am Heart J 5 1994 1316 1328
6. G. Bondjers Anti-atherosclerotic effects of beta-blockers Eur Heart J 15 suppl 1994 C8 C15
7. W.H. Frishman, E.J. Lazar Reduction of mortality, sudden death and non-fatal reinfarction with beta-adrenergic blockers in survivors of acute myocardial infarction: a new hypothesis regarding the cardioprotective action of beta-adrenergic blockade Am J Cardiol 66 suppl 1990 66G 70G
8. H.J. Dargie Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 2001 1385 1390
9. The SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions N Engl J Med 327 1992 685 691
10. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
11. S. Yusuf, C.J. Pepine, C. Garces, H. Pouleur, D. Salem, J. Kostis, C. Benedict, M. Rousseau, M. Bourassa, B. Pitt Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions Lancet 340 1992 1173 1178
12. M. Packer, P.A. Poole-Wilson, P.W. Armstrong, J.G. Cleland, J.D. Horowitz, B.M. Massie, L. Ryden, K. Thygesen, B.F. Uretsky Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure ATLAS Study Group Circulation 100 1999 2312 2318
13. M. Packer, M.R. Bristow, J.N. Cohn, W.S. Colucci, M.B. Fowler, E.M. Gilbert, N.H. Shusterman U.S. Carvedilol Heart Failure Study Group The effect of carvedilol on morbidity and mortality in patients with chronic heart failure N Engl J Med 334 1996 1349 1355
14. R.M. Califf, K.F. Adams, W.J. McKenna, M. Gheorghiade, B.F. Uretsky, S.E. McNulty, H. Darius, K. Schulman, F. Zannad, E. Handberg-Thurmond A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST) Am Heart J 134 1997 44 54
15. CIBIS Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II). a randomised trial. Lancet 1999;353:9-13.
16. The MERIT-HF Study Group Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
17. J.N. Cohn, G. Tognoni Valsartan Heart Failure Trial Investigators A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 2001 1667 1675
18. M. Packer, A.J. Coats, M.B. Fowler, H.A. Katus, H. Krum, P. Mohacsi, J.L. Rouleau, M. Tendera, A. Castaigne, E.B. Roecker Carvedilol Prospective Randomized Cumulative Survival Study Group Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
19. The Beta-Blocker Evaluation of Survival Trial Investigators A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure N Engl J Med 344 2001 1659 1667
20. The Randomized Aldactone Evaluation Study (RALES) Investigators Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure Am J Cardiol 78 1996 902 907
21. M.A. Pfeffer, J.J. McMurray, E.J. Velazquez, J.L. Rouleau, L. Kober, A.P. Maggioni, S.D. Solomon, K. Swedberg, F. Van de Werf, H. White Valsartan in Acute Myocardial Infarction Trial Investigators Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both N Engl J Med 349 2003 1893 1906
22. M. Packer, C.M. O'Connor, J.K. Ghali, M.L. Pressler, P.E. Carson, R.N. Belkin, A.B. Miller, G.W. Neuberg, D. Frid, J.H. Wertheimer Prospective Randomized Amlodipine Survival Evaluation Study Group Effect of amlodipine on morbidity and mortality in severe chronic heart failure N Engl J Med 335 1996 1107 1114
23. L. Kober, C. Torp-Pedersen, J.E. Carlsen, H. Bagger, P. Eliasen, K. Lyngborg, J. Videback, D.S. Cole, L. Auclert, N.C. Pauly Trandolapril Cardiac Evaluation (TRACE) Study Group A clinical trial of the angiotensin-converting- enzyme inhibitor trandolapril in patient with left ventricular dysfunction after myocardial infarction N Engl J Med 333 1995 1670 1676
24. P.A. Poole-Wilson, K. Swedberg, J.G. Cleland Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 2003 7 13
25. J.J. McMurray, J. Ostergren, K. Swedberg, C.B. Granger, P. Held, E.L. Michelson, B. Olofsson, S. Yusuf, M.A. Pfeffer CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting enzyme inhibitors: the CHARM-Added trial Lancet 362 2003 767 771
26. The BEST Steering Committee Design of the Beta-Blocker Evaluation Survival Trial (BEST) Am J Cardiol 75 1995 1220 1223
27. J. He, L.G. Ogden, L.A. Bazzano, S. Vupputuri, C. Loria, P.K. Whelton Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study Arch Intern Med 161 2001 996 1002
28. E. Braunwald, E.M. Antman, J.W. Beasley, R.M. Califf, M.D. Cheitlin, J.S. Hochman, R.H. Jones, D. Kereiakes, J. Kupersmith, T.N. Levin American College of Cardiology; American Heart Association ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the ACC/AHA task force on practice guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll Cardiol 40 2002 1366 1374